Effectiveness of SARS-CoV-2 Testing Strategies

Overview

Journal Cochrane Database Syst Rev

Publisher Wiley

Specialties General Medicine
Health Services

Date 2025 Feb 24

PMID 39991854

Authors

K M Saif-Ur-Rahman

Nadra Nurdin

Ani Movsisyan

Kavita Kothari

Thomas Conway

Marie Tierney

Petek Eylul Taneri

Deirdre Mulholland

Andrea C Tricco

Jacqueline Dinnes

Declan Devane

Affiliations

Soon will be listed here.

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effectiveness of different SARS-CoV-2 testing strategies in reducing COVID-19 cases, hospitalisations, and deaths among suspected cases and asymptomatic individuals.

References

Huguet-Torres A, Castro-Sanchez E, Capitan-Moyano L, Sanchez-Rodriguez C, Bennasar-Veny M, Yanez A . Personal protective measures and settings on the risk of SARS-COV-2 community transmission: a case-control study. Front Public Health. 2024; 11:1327082. PMC: 10801386. DOI: 10.3389/fpubh.2023.1327082. View

Lee B . Why Does the SARS-CoV-2 Delta VOC Spread So Rapidly? Universal Conditions for the Rapid Spread of Respiratory Viruses, Minimum Viral Loads for Viral Aerosol Generation, Effects of Vaccination on Viral Aerosol Generation, and Viral Aerosol Clouds. Int J Environ Res Public Health. 2021; 18(18). PMC: 8470664. DOI: 10.3390/ijerph18189804. View

Peters J, Farhadloo M . The Effects of Non-Pharmaceutical Interventions on COVID-19 Cases, Hospitalizations, and Mortality: A Systematic Literature Review and Meta-Analysis. AJPM Focus. 2023; :100125. PMC: 10265928. DOI: 10.1016/j.focus.2023.100125. View

Peeling R, Heymann D, Teo Y, Garcia P . Diagnostics for COVID-19: moving from pandemic response to control. Lancet. 2021; 399(10326):757-768. PMC: 8687671. DOI: 10.1016/S0140-6736(21)02346-1. View

Georgakopoulou V, Gkoufa A, Makrodimitri S, Basoulis D, Tsakanikas A, Karamanakos G . Early 3‑day course of remdesivir for the prevention of the progression to severe COVID‑19 in the elderly: A single‑centre, real‑life cohort study. Exp Ther Med. 2023; 26(4):462. PMC: 10469144. DOI: 10.3892/etm.2023.12161. View

McGowan J, Sampson M, Salzwedel D, Cogo E, Foerster V, Lefebvre C . PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol. 2016; 75:40-6. DOI: 10.1016/j.jclinepi.2016.01.021. View

Al-Awwal N, Dweik F, Mahdi S, El-Dweik M, Anderson S . A Review of SARS-CoV-2 Disease (COVID-19): Pandemic in Our Time. Pathogens. 2022; 11(3). PMC: 8951506. DOI: 10.3390/pathogens11030368. View

Tatsuki O, Naoki H, Igarashi Y . Optimal COVID-19 testing strategy on limited resources. PLoS One. 2023; 18(2):e0281319. PMC: 9956024. DOI: 10.1371/journal.pone.0281319. View

Page M, Sterne J, Boutron I, Hrobjartsson A, Kirkham J, Li T . ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis. BMJ. 2023; 383:e076754. DOI: 10.1136/bmj-2023-076754. View

10.

Sterne J, Savovic J, Page M, Elbers R, Blencowe N, Boutron I . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898. DOI: 10.1136/bmj.l4898. View

11.

Lauer S, Grantz K, Bi Q, Jones F, Zheng Q, Meredith H . The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020; 172(9):577-582. PMC: 7081172. DOI: 10.7326/M20-0504. View

12.

Lison A, Banholzer N, Sharma M, Mindermann S, Unwin H, Mishra S . Effectiveness assessment of non-pharmaceutical interventions: lessons learned from the COVID-19 pandemic. Lancet Public Health. 2023; 8(4):e311-e317. PMC: 10036127. DOI: 10.1016/S2468-2667(23)00046-4. View

13.

Foulkes S, Monk E, Sparkes D, Hettiarachchi N, Milligan I, Munro K . Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021-September 2022. Emerg Infect Dis. 2022; 29(1):184-188. PMC: 9796219. DOI: 10.3201/eid2901.221293. View

14.

Evans R, Dube S, Lu Y, Yates M, Arnetorp S, Barnes E . Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study. Lancet Reg Health Eur. 2023; 35:100747. PMC: 10730312. DOI: 10.1016/j.lanepe.2023.100747. View

15.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

16.

Sterne J, Hernan M, Reeves B, Savovic J, Berkman N, Viswanathan M . ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016; 355:i4919. PMC: 5062054. DOI: 10.1136/bmj.i4919. View

17.

da Silva S, do Nascimento J, Mendes R, Guarines K, Targino Alves da Silva C, Silva P . Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis. 2022; 8(9):1758-1814. PMC: 9380879. DOI: 10.1021/acsinfecdis.2c00204. View

18.

Stegeman I, Ochodo E, Guleid F, Holtman G, Yang B, Davenport C . Routine laboratory testing to determine if a patient has COVID-19. Cochrane Database Syst Rev. 2020; 11:CD013787. PMC: 8078159. DOI: 10.1002/14651858.CD013787. View

19.

Dyer A, Fallon A, Noonan C, Dolphin H, OFarrelly C, Bourke N . Managing the Impact of COVID-19 in Nursing Homes and Long-Term Care Facilities: An Update. J Am Med Dir Assoc. 2022; 23(9):1590-1602. PMC: 9250924. DOI: 10.1016/j.jamda.2022.06.028. View

20.

Wang B, Andraweera P, Elliott S, Mohammed H, Lassi Z, Twigger A . Asymptomatic SARS-CoV-2 Infection by Age: A Global Systematic Review and Meta-analysis. Pediatr Infect Dis J. 2023; 42(3):232-239. PMC: 9935239. DOI: 10.1097/INF.0000000000003791. View